🇺🇸 FDA
Patent

US 11980659

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

granted A61KA61K2039/53A61K2039/884

Quick answer

US patent 11980659 (Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same) held by Inovio Pharmaceuticals, Inc. expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/53, A61K2039/884, A61K39/00, A61K39/0011